Author: Shannon Palus

Editors weren’t “unable to verify reviewer identities” — reviewers just weren’t qualified

cover_image_archive_default

We can’t resist flagging some misleading language in a retraction note for a 2015 paper on the inner workings of an amoeba pathogen.

The note for “The Charms of the CHRM Receptors: Apoptotic and Amoebicidal effects of Dicyclomine on Acanthamoeba castellanii” is short, so we’re going to give it to you up front:

This accepted manuscript has been retracted because the journal is unable to verify reviewer identities.

Sounds like another case of faked emails to generate fake peer reviews, right? But that’s not what happened to this paper, according to the editor in chief of Antimicrobial Agents and Chemotherapy, Louis B. Rice, a professor at Brown University:

Continue reading Editors weren’t “unable to verify reviewer identities” — reviewers just weren’t qualified

“Carelessness” forces Science to correct paper about immune booster

F1.medium (1)

Science is fixing images in a paper published online in April that discovered an immune-boosting protein, after the authors mistakenly mixed up similar-looking Western blots.

The paper, which received some press coverage, identified a protein that helped the immune system fight off cancers and infections. Philip Ashton-Rickardt, a scientist at Imperial College London who led the study, told the The Telegraph:

This is exciting because we have found a completely different way to use the immune system to fight cancer.

The editor in chief of Science, Marcia McNutt, told us that the journal contacted the authors once it learned of “irregularities” in some of the figures, which did not affect the conclusions of the paper:

Plagiarism detected in two papers on improving detection of cancer by mammograms

8 (1)

A group of computer scientists has a pair of retractions for duplicating “substantial parts” of other articles written by different authors. Both papers, published in Neural Computing and Applications, are on ways to screen for breast cancer more effectively.

According to the abstract of  “An improved data mining technique for classification and detection of breast cancer from mammograms,” computers make the process of identifying cancer in lesions detected by mammograms faster and more accurate:

Although general rules for the differentiation between benign and malignant breast lesion exist, only 15–30% of masses referred for surgical biopsy are actually malignant. Physician experience of detecting breast cancer can be assisted by using some computerized feature extraction and classification algorithms. Computer-aided classification system was used to help in diagnosing abnormalities faster than traditional screening program without the drawback attribute to human factors.

The article has been cited four times, according to Thomson Scientific’s Web of Knowledge.  The retraction note reveals where “substantial parts” of the article came from:

Continue reading Plagiarism detected in two papers on improving detection of cancer by mammograms

Chronic fatigue syndrome-XMRV researcher scheduled to head to court today, alleging conspiracy

Judy Mikovits
Judy Mikovits

Chronic fatigue syndrome researcher Judy Mikovits was scheduled to head is heading to court today, where a California judge will would decide whether or not to dismiss her lawsuit against fourteen people and two Nevada corporations.

(Note: This story has been updated. See below.)

Among the defendants: the Whittemore Peterson Institute  in Reno, Nevada where Mikovits used to work; the institute’s cofounders, Annette and Harvey Whittemore; a colleague with whom she shares a retracted Science paper; and several members of California and Nevada law enforcement.

The complaint does not check the box next to “Money Demanded in Complaint”, but also lists $750,000 in the associated field:

Screen Shot 2015-11-16 at 11.28.23 AM

In 2006, Mikovits began working for the Whittmores at the WPI; her job was to search for a biological cause of chronic fatigue, a vexing, mysterious disease afflicting their daughter. Part of her research focused on a potential link between chronic fatigue syndrome and a virus known as XMRV. But after others — and Mikovits herself — couldn’t replicate results published in Science and the paper was retracted, she was fired from her position in 2011. Mikovits alleges that Continue reading Chronic fatigue syndrome-XMRV researcher scheduled to head to court today, alleging conspiracy

Nutritionist group pulls position statement on vegetarian diets for “inaccuracies and omissions”

Screen Shot 2015-10-16 at 11.57.38 AMWhat are the specific health benefits to skipping out on meat? We’re not totally sure, after the largest organization for nutrition professionals pulled its 2015 position statement on this issue only weeks after publishing it in the Journal of the Academy of Nutrition and Dietetics.

The “Position of the Academy of Nutrition and Dietetics: Vegetarian Diets” was removed earlier this year for “inaccuracies and omissions critical to the paper” — and the first author wasn’t told what they were. A “major revision” is forthcoming.

Here’s the removal note from the journal for the 2015 version:

Continue reading Nutritionist group pulls position statement on vegetarian diets for “inaccuracies and omissions”

Heart researcher who faked patient data gets 4th retraction

XLargeThumb.00004872-201512000-00000.CVA heart researcher who fabricated patient records for her studies on the blood pressure medication ramipril has earned her fourth retraction, and more are apparently on the way.

For readers who are new to this case: Things first unraveled for Anna Ahimastos when a subanalysis of a JAMA clinical trial revealed “anomalies,” triggering an investigation. After Ahimastos admitted to fabricating patient data, that JAMA paper and two others — including a small trial in Annals of Internal Medicine — were pulled. A spokesperson for her former employer, Baker IDI Heart & Diabetes Institute, told us last week that they have requested more retractions:

Five papers and one letter are in the process of being retracted.

The Annals and this latest paper are included in the five papers, so we expect to see Continue reading Heart researcher who faked patient data gets 4th retraction

A bacterium may be anti-fungal, but it’s not anti-retraction

6

The authors of a paper on an anti-fungal bacterium couldn’t ward off a very common problem: plagiarism. The people credited on the paper, published in Applied Microbiology and Biotechnology, apparently weren’t the original authors, according to the retraction note.

We’re not sure who the original authors are. The retraction note doesn’t elaborate much:

Continue reading A bacterium may be anti-fungal, but it’s not anti-retraction

Psychologist Jens Forster settles case by agreeing to 2 retractions

forster-j-a
Jens Förster

Following questions about the veracity of multiple papers by his former employer, high-profile social psychologist Jens Förster has agreed to retract two papers as part of a deal with the German Society for Psychology (DGPs).

Last year, Förster had a paper retracted at the request of his former employer, the University of Amsterdam (UvA). In May, an investigation commissioned by UvA found that many of his experiments looked “too good to be true,” and eight papers showed strong signs of “low veracity.”

Just two of those papers are acknowledged in the settlement of a case by the DGPs against Förster, who currently works at Ruhr University Bochum. Here’s a translation of a notice from the DGPs from One Hour Translation:

Continue reading Psychologist Jens Forster settles case by agreeing to 2 retractions

When a paper is retracted, so is its previous correction–sometimes

1-s2.0-S0968089612X0018X-cov150hSometimes, the path to correcting the scientific record takes a few turns. In the case of a paper about a new cancer compound, authorship issues led to a correction and, ultimately, a retraction — along with a double-back to retract the earlier correction.

We reported on the first part of the story back in January: A 2011 paper that described a novel compound that could work as a drug for the side effects of chemotherapy was corrected in 2012 to add additional authors. But once the authors realized their supposedly novel compound had actually been synthesized by another author, they decided to retract the paper from Bioorganic and Medicinal Chemistry earlier this year, concluding “these facts made the paper inappropriate and unfaithful.”

Apparently, around the same time, the authors decided to retract the earlier correction, as well:

Continue reading When a paper is retracted, so is its previous correction–sometimes

BMC retracts paper by scientist who banned use of his software by immigrant-friendly countries

Screen Shot 2015-11-10 at 12.24.42 PMA BioMed Central journal has pulled the paper of a scientist who decided to prohibit countries that are friendly to immigrants from using his software.

Recently, German scientist Gangolf Jobb declared that starting on October 1st scientists working in countries that are, in his opinion, too welcoming to immigrants — including Great Britain, France and Germany — could no longer use his Treefinder software, which creates trees showing potential evolutionary relationships between species. He’d already banned its use by U.S. scientists in February, citing the country’s “imperialism.” Last week, BMC Evolutionary Biology pulled the paper describing the software, noting it now “breaches the journal’s editorial policy on software availability.”

Many scientists have used Jobb’s software: The BMC paper that describes it, “TREEFINDER: a powerful graphical analysis environment for molecular phylogenetics,” has been cited 745 times since it was published in 2004, according to Thomson Scientific’s Web of Knowledge.

Jobb told Retraction Watch that the software is still available to any scientist willing to travel to non-banned countries, and that he does not care about the retraction: Continue reading BMC retracts paper by scientist who banned use of his software by immigrant-friendly countries